Dofort Pharma Private Limited - Due diligence report
A 360° intelligence report on Dofort Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Dofort Pharma Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsDofort Pharma Private Limited is assessed as Low Risk with a Trust Score of 94/100. Dofort Pharma Private Limited is an active private limited indian non-government company incorporated in 2006, operating in the Financial Services sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 01 Aug 2026 from the latest processed filings. Dofort Pharma Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 4 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RAJAN PRIYAKANT PARIKH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JAYANTILAL PATEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KIRIT CHIMANBHAI TULSIBHAI PATEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JAYESH JITENDRA PARIKH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JAYANTI CHIMANBHAI PATEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 5 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
As per FY 2016 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 90 · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Iifl Finance | U28999MH1997PTC110615 | Mumbai, Maharashtra, India |
| Suraiya Minerals & Chemicals Pvt Ltd | U67190WB1939PTC009909 | Kolkata, West Bengal, India |
| Vakharia Financial Services Limited | U65910MH1995PLC085686 | Mumbai, Maharashtra, India |
| Saikirpa Tradex Private Limited | U51909DL2007PTC165063 | New Delhi, Delhi, India |
| Mahendra Shipping Limited | U61110DL1981PLC012573 | New Delhi, Delhi, India |
| Future Vision Exim Private Limited | U51311DL2003PTC119321 | Delhi, Delhi, India |
| Pou Chong Properties Private Limited | U45201WB1999PTC090465 | Kolkata, West Bengal, India |
| Saraf Enterprises Private Limited | U29219AP1990PTC011582 | Visakhapatnam, Andhra Pradesh, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Dofort Pharma Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Dofort Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Dofort Pharma Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 94/100, distress signals and MSME payment-delay disclosures - know whether Dofort Pharma Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Dofort Pharma Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Dofort Pharma Private Limited an active company?
Dofort Pharma Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).
Is Dofort Pharma Private Limited financially healthy?
Dofort Pharma Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Dofort Pharma Private Limited?
Its overall Trust Score is 94/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Dofort Pharma Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.
Does Dofort Pharma Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Dofort Pharma Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).
Is it risky to lend to Dofort Pharma Private Limited?
Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.